CA2364131A1 - Implantable stroke preventing device - Google Patents
Implantable stroke preventing device Download PDFInfo
- Publication number
- CA2364131A1 CA2364131A1 CA002364131A CA2364131A CA2364131A1 CA 2364131 A1 CA2364131 A1 CA 2364131A1 CA 002364131 A CA002364131 A CA 002364131A CA 2364131 A CA2364131 A CA 2364131A CA 2364131 A1 CA2364131 A1 CA 2364131A1
- Authority
- CA
- Canada
- Prior art keywords
- deflecting
- carotid artery
- ica
- eca
- cca
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/856—Single tubular stent with a side portal passage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/954—Instruments specially adapted for placement or removal of stents or stent-grafts for placing stents or stent-grafts in a bifurcation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/016—Filters implantable into blood vessels made from wire-like elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2002/018—Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/061—Blood vessels provided with means for allowing access to secondary lumens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/068—Modifying the blood flow model, e.g. by diffuser or deflector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0015—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in density or specific weight
- A61F2250/0017—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in density or specific weight differing in yarn density
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0023—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
- A61F2250/0024—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity made from both porous and non-porous parts, e.g. adjacent parts
Abstract
An implantable device (20) for positioning in the vicinity of the bifurcatio n of the common carotid artery (CCA) (38) into the internal carotid artery (IC A) (40) and the external carotid artery (ECA) (42) comprises a deflecting eleme nt (24) suitable to deflect the flow (60) of embolic material flowing in the CC A (38) toward the ICA (40), into the ECA (42).
Description
IMPLANTABLE STROKE PREVENTING DEVICE
FIELD OF THE INVENTION
The present invention relates to implantable stroke treating devices, and more specifically is concerned with a device for reducing the risk of embolic material entering into the internal carotid artery of an individual and blood clots (collectively and interchangeably referred to as 'embolic material'.
BACKGROUND OF THE INVENTION
A major portion of blood supply to the brain hemispheres is by two arteries, referred to as common carotid arteries (CCA), each of which branches off, or bifurcates as the term is at times used, into a so-called internal carotid artery (ICA) and an external carotid artery (ECA). Blood to the brain stem is supplied by two vertebral arteries.
Cerebralvascular diseases are considered among the leading causes of mortality and morbidity in the modern age. Strokes denote an abrupt impairment of brain function caused by pathologic changes occurring in blood vessels. The main cause of strokes is insufficient blood ilow to the brain (referred to as '~zn ischemic strohe'~ which are about 80°/ of stroke cases.
Ischemic strokes are caused by sudden occlusion of an artery supplying blood to the brain. Occlusion or partial occlusion (stenosis) are the result of diseases of the arterial wall. Arterial atherosclerosis is by far the most common arterial disorder, and when complicated by
FIELD OF THE INVENTION
The present invention relates to implantable stroke treating devices, and more specifically is concerned with a device for reducing the risk of embolic material entering into the internal carotid artery of an individual and blood clots (collectively and interchangeably referred to as 'embolic material'.
BACKGROUND OF THE INVENTION
A major portion of blood supply to the brain hemispheres is by two arteries, referred to as common carotid arteries (CCA), each of which branches off, or bifurcates as the term is at times used, into a so-called internal carotid artery (ICA) and an external carotid artery (ECA). Blood to the brain stem is supplied by two vertebral arteries.
Cerebralvascular diseases are considered among the leading causes of mortality and morbidity in the modern age. Strokes denote an abrupt impairment of brain function caused by pathologic changes occurring in blood vessels. The main cause of strokes is insufficient blood ilow to the brain (referred to as '~zn ischemic strohe'~ which are about 80°/ of stroke cases.
Ischemic strokes are caused by sudden occlusion of an artery supplying blood to the brain. Occlusion or partial occlusion (stenosis) are the result of diseases of the arterial wall. Arterial atherosclerosis is by far the most common arterial disorder, and when complicated by
-2-thrombosis or embolism it is the most frequent cause of cerebral ischemia and infarction, eventually causing the cerebral stroke.
Cardioembolism causes about 15%-20% of all strokes. Stroke caused by heart disease is primarily due to embolism of thrombotic material forming on the atrial or ventricular wall or the left heart valves. These thrombi then detach and embolize into the arterial circulation. Emboli large enough can occlude large arteries in the brain territory and cause strokes.
Cardiogenetic cerebral embolism is presumed to have occurred when cardiac arrhythmia or structural abnormalities are found or known to be present. The most common causes of cardioembolic stroke are nonrheumatic (non-valvular) atrial fibrillation (A~, prothestic valves, rheumatic heart disease (R,HD), ischemic cardiomyopathy, congestive heart failure, myocardial infarction, post-operatory state and protruding aortic arch atheroma (A.A.A.).
Such disorders are currently treated in different ways such as by drug management, surgery (carotid endarterectomy) in case of occlusive disease, or carotid angioplasty and carotid stems.
While endarterectomy, angioplasty and carotid stenting are procedures targeting at opening the occluded artery, they do not prevent progression of new plaque. Even more so, the above treatment methods only provide a solution to localized problems and do not prevent proximal embolic sources, i.e. embolus formed at remote sites (heart and ascending aorta) to pass through the reopened stenosis in the carotid
Cardioembolism causes about 15%-20% of all strokes. Stroke caused by heart disease is primarily due to embolism of thrombotic material forming on the atrial or ventricular wall or the left heart valves. These thrombi then detach and embolize into the arterial circulation. Emboli large enough can occlude large arteries in the brain territory and cause strokes.
Cardiogenetic cerebral embolism is presumed to have occurred when cardiac arrhythmia or structural abnormalities are found or known to be present. The most common causes of cardioembolic stroke are nonrheumatic (non-valvular) atrial fibrillation (A~, prothestic valves, rheumatic heart disease (R,HD), ischemic cardiomyopathy, congestive heart failure, myocardial infarction, post-operatory state and protruding aortic arch atheroma (A.A.A.).
Such disorders are currently treated in different ways such as by drug management, surgery (carotid endarterectomy) in case of occlusive disease, or carotid angioplasty and carotid stems.
While endarterectomy, angioplasty and carotid stenting are procedures targeting at opening the occluded artery, they do not prevent progression of new plaque. Even more so, the above treatment methods only provide a solution to localized problems and do not prevent proximal embolic sources, i.e. embolus formed at remote sites (heart and ascending aorta) to pass through the reopened stenosis in the carotid
-3-and occlude smaller arteries in the brain. This is a substantial problem, inasmuch as about one-third of patients suffering front carotid occlusion also have proximal embolic sources leading to stroke. It should be noted that only about 20% of the cases of stroke result from an occlusion of the carotid.
It will also be appreciated that endarterectomy is not suitable for intracarnial arteries or in the. vertebrobasilar system since these arteries are positioned within unacceptable environment (brain tissue, bone tissue) or are too small in diameter.
Introducing filtering means into blood vessels, in particular into veins, has been known for some time. However, filtering devices known in the art are generally of a complex design, which renders such devices unsuitable for implantation within carotid arteries, and unsuitable for handling fine embolic material. However, when considering the possible cerebral effects of even fine embolic material occluding an artery supplying blood to the brain, the consequences may be fatal or may cause irreversible brain damage.
However, in light of the short period of time during which brain tissue can survive without blood supply, there is significant importance to providing suitable means for preventing even small embolic material from entering the internal carotid artery, so as to avoid brain damage.
A drawback of prior art filtering means is their tendency to become clogged. On the one hand, in order to provide efficient filtering
It will also be appreciated that endarterectomy is not suitable for intracarnial arteries or in the. vertebrobasilar system since these arteries are positioned within unacceptable environment (brain tissue, bone tissue) or are too small in diameter.
Introducing filtering means into blood vessels, in particular into veins, has been known for some time. However, filtering devices known in the art are generally of a complex design, which renders such devices unsuitable for implantation within carotid arteries, and unsuitable for handling fine embolic material. However, when considering the possible cerebral effects of even fine embolic material occluding an artery supplying blood to the brain, the consequences may be fatal or may cause irreversible brain damage.
However, in light of the short period of time during which brain tissue can survive without blood supply, there is significant importance to providing suitable means for preventing even small embolic material from entering the internal carotid artery, so as to avoid brain damage.
A drawback of prior art filtering means is their tendency to become clogged. On the one hand, in order to provide efficient filtering
-4-means, the filter should be of fine mesh. On the other hand, a fine mesh has a higher tendency toward, and risk of, occlusion.
It should also be noted that the flow ratio between the ICA and the ECA is about 4:1. This ratio also reflects the much higher risk of embolic material flowing into the ICA.
It is thus an object of the present invention to provide an implantable deflecting device suitable to be positioned within a blood vessel supplying blood to the brain, and further suitable to deflect embolic material that would have flown into the internal carotid artery, into the external carotid artery, thereby preventing the entry of said embolic material into the internal carotid artery, and thus preventing extracarnial embolus to occlude small intercarnial arteries in the brain.
It is another object of the invention to provide a method for treating a patient known to suffer from embolic diseases, by selectively occluding the passage of embolic material into the internal carotid artery.
It is yet another object of the invention to provide a method for preventing conditions associated with embolic material.
Other objects of the invention will become apparent as the description proceeds.
SUMMARY OF THE INVENTION
The present invention provides an implantable device for positioning in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), comprising a deflecting element suitable to deflect the flow of embolic material flowing in the CCA toward the ICA, into the ECA. Preferably, but non-limitatively, the deflecting element comprises filtering means.
Thus, in one aspect, the invention provides an implantable deflecting device comprising an anchoring member engageable with inner walls of a carotid artery, and one or more deflecting members for deflecting flow of embolic material into the ECA, substantially without obstructing blood flow into the ICA.
The anchoring member and the deflecting member may be integral with one another or attached or coupled to one another. In the present specification the anchoring member and the deflecting member may be referred to also as anchoring portion and deflecting portion, respectively.
In accordance with a particular preferred embodiment of the invention, the deflecting member is a screening element fitted at the inlet into the ICA and is adapted to prevent the passage into the ICA of embolic material above a predetermined size.
By a preferred embodiment, at least the anchoring member is a stmt adapted for insertion via the vasculature of an individual. The implantable deflecting device in accordance with any of the .6_ embodiments of the present invention may be permanently implanted or may be removed after a period of time, depending on the course of treatment and the medical procedure.
As will become evident from the description to follow, the deflecting member is preferably, but not compulsorily, positioned at the inlet into the internal carotid artery, whereas the anchoring member may be positioned in a variety of locations. The deflecting member, however, may be positioned at any location that fulfills two conditions:
firstly, it does not occlude the flow of blood into the ICA, and secondly, it causes a deflection of the flow of embolic material into the ECA. For instance, the deflecting member may be anchored in the ICA and protrude into the bifurcation zone, or may be positioned at the entrance to the ECA and extend toward the surrounding walls, for constructive and strength reasons.
In accordance with one specific embodiment of the invention, the anchoring member comprises a tubular portion for anchorage within the CCA with an upstream portion extending towards the bifurcation zone, said upstream portion accommodating the one or more deflecting member.
In accordance with still another preferred embodiment of the invention, the anchoring member comprises a tubular portion for anchoring within the ECA, with a downstream portion extending towards the bifurcation zone, said downstream portion accommodating the one or more deflecting member. Alternatively, the anchoring member comprises a tubular portion for anchorage within the ICA, with a downstream portion extending towards the bifurcation zone, said upstream portion accommodating the one or more deflecting member.
It will also be appreciated that the anchoring member may comprise a tubular portion for anchorage within a vascular portion extending along the CCA and .the ECA, wherein the one or more deflecting members is accommodated at the inlet to the ICA.
By one specific design the anchoring member comprises a tubular portion for anchorage at the bifurcation zone, wherein the one or more deflecting member is accommodated at or adjacent the inlet into the ICA.
The one or more deflecting member may be integrally formed with the anchoring member or may be attached or coupled thereto either during manufacture, or after implanting the anchoring member within the artery.
By another aspect of the present invention there is provided an implantable deflecting device for implanting at the vicinity of bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA); the device comprising an anchoring member engageable with inner walls of a carotid artery, and one or more deflecting members, wherein the one or more deflecting member is so positioned and sized so that embolic material encountering it is deflected to flow into the ECA.
_$_ In another aspect the invention is directed to an arterial stent suitable to be positioned in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), comprising a deflecting device.
The invention is further directed to an arterial stmt suitable to be positioned in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), coupled to a deflecting device.
Preferably, but non-limitatively, the aforementioned stents employ as a deflecting device an element comprising filtering means of dimensions suitable to allow the flow of blood to proceed into the ICA, while preventing the access thereto of embolic material of a predetermined size.
In a further aspect, the invention is directed to the prevention of the occurrence, or the recurrence, of cerebralvascular diseases, particularly of stroke, comprising 'preventing the flow of embolic material flowing in the CCA from accessing the ICA, by deflecting the flow of said embolic material into the ECA. Prevention of the cerebralvascular disease is achieved by implanting, permanently or temporarily, in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), a deflecting device according to the invention.
It should be emphasized that while throughout this specification reference is made to the bifurcation of the CCA into the ICA, this is done for the sake of brevity only, but the invention is in no way limited _g_ to this specific location. The invention can be advantageously be exploited at any other suitable bifurcation of blood vessels as existing, for instance, in the leg.
All the above and other characteristics and advantages of the invention will be better understood through the following illustrative and non-limitative detailed description of preferred embodiments thereof.
BRIEF DESCRIPTION OF THE DRAWINGS
In order to better understand the invention and to illustrate it in practice, non-limiting examples of some preferred embodiments will now be described, with reference to the accompanying drawings, in which:
Fig. 1A is a perspective view of a deflecting member in accordance with a preferred embodiment of the present invention;
Fig. 1B is a perspective view of a deflecting member according to another preferred embodiment of the invention, which is a modification of the device of Fig. 1A;
Fig. 2 illustrates the insertion and positioning of a device according to a preferred embodiment of the invention:
Fig. 2A schematically shows the deflecting device of Fig. 1, in .
collapsed form (i.e., prior to expansion into the artery), on its way to reach the arterial bifurcation; Fig. 2B schematically shows the deflecting device of Fig. 2A, during its expansion and positioning at the arterial bifurcation;
Fig. 2C shows a situation in which the device of Fig. 1 has been positioned in the bifurcation, and the deploying equipment has been withdrawn (normal working position);
Fig. 3A schematically illustrates a deflecting device in accordance with another embodiment of the invention, located within the internal carotid artery;
Fig. 3B schematically illustrates the stages of insertion of the device of Fig, 3A;
Fig. 4 is a deflecting device wherein the anchoring portion mainly extends into the external carotid artery;
Fig. 5 is a deflecting device in which the anchoring portion extends mainly in the common carotid artery;
Fig. 6 is a deflecting device in which the anchoring portion is located at the bifurcation zone;
Fig. 7 schematically illustrates the insertion of a self expandable device; and Fig. 8 schematically shows how to deal with a bifurcation lesion, according to one preferred embodiment of the invention.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
A deflecting device in accordance with a preferred embodiment of the present invention, generally designated 20, is shown in Fig. 1A. The deflecting device is made of fine wire woven into a net-like device having a construction suitable for expanding from a contracted position in which it is deployed through the vasculator of an individual, and expanded by means well known in the art, as will be further explained hereinafter with reference to Figs. 2A and 2B.
The deflecting device 20 has an essentially cylindrical shape with its body 22 generally serving as an anchoring portion. An anchoring portion is a portion of the device that firmly contacts the walls of the artery. Such contact causes a growth of the wall into the net of the devices, and strongly anchors it to the artery thus preventing its accidental displacement. The physiological processes leading to such anchoring are well known in the art, and will therefore not be discussed herein in detail, for the sake of brevity.
A deflecting portion 24 is constructed by a plurality of fine wires 26, parallelly extending along the longitudinal axis of the device and supported by two support wires 28. The deflecting portion 24 is integral with or attached to the anchoring portion 22.
The size and shape of the deflecting member is adjusted to match the inlet of the internal carotid artery as will be further explained hereinafter.
The embodiment of Fig. 1B is similar to that of Fig. lA. However, the deflecting device 21, which is essentially cylindrical, comprises a deflecting portion 25 which is not limited to a part of the circumference of the device, as is the deflecting portion 24 of Fig. 1A, but rather covers the whole circumference of the device. This arrangement, of course, is easier to use, inasmuch as there is no need to exactly match the limited area of the deflecting portion with the opening of the ICA. Furthermore, two markers 27 (which in the particular embodiment of Fig. 1B are circular in shape) are provided, which are radio opaque and serve to aid a physician in the proper positioning of the device within the artery. The markers are visible under radiographic equipment, and therefore can be used to follow the advancement of the device that bears them. Other markers can also be provided, as will be apparent to the skilled person.
For instance, markers 27a are gold points which may be used to position the device also with respect of its rotation around its axis.
The structure of the anchoring portion 29 and of the deflecting portion 25 is essentially similar to the structure illustrated with reference to Fig. lA. The difference resides mainly in the design of the deflecting portion, and in the provision of the markers.
Figs. 2A through 2Cillustrates a carotid artery portion, generally designated 36, in which the common carotid artery (CCA) is designated 38, the internal carotid artery (ICA) is designated 40, and the external carotid artery (ECA) is designated 42. For placing the deflecting device 20 seen in Fig. 1, conventional stmt deployment equipment may be used, which equipment typically comprises an expandable balloon 46, fitted at an end of an inflating tube 48 carried by a guide wire (not seen). However, the device may also be self expandable, as known per se, and as readily understood by the skilled person.
The arrangement is such that by using suitable imaging equipment, the assembly seen in Fig. 2A is inserted through the vasculator of an individual, into the CCA, until the deflecting device 20 is positioned within the bifurcation zone 52, with the deflecting member 24 extending opposite inlet 54 of ICA 40. In this position, balloon 46 is inflated, as shown in Fig. 2B, whereby the anchoring walls 22 of deflecting device 20 anchor against respective inner walls of the common carotid artery 38 and the external carotid artery 42, respectively, with the deflecting member 24 extending across inlet 54 of the internal carotid artery 40. Then, balloon 46 is deflated and is removed via the vasculator of the individual, and the deployment of the deflecting member 20 is thus completed, as seen in Fig. 2C. In this position, embolic material, which is schematically illustrated as particles flowing along flow lines 60 in Fig. 2C, flow in the common carotid artery 38, and upon meeting the deflecting member 24 they are prevented from entering the ICA 40, because their size is larger than the mesh of deflecting portion 24, and they are thus deflected into the external carotid artery 42.
The corresponding operation, when effected with a self expandable stmt, is illustrated in Fig. 7. As will be apparent to the skilled person, using a self expandable device is more convenient in many cases, because of the great mobility of the neck of the patient. The self expandable device, of course, provides for a better anchoring of the device.
Fig. 7A shows the stmt in folded state, Fig. 7B shows it during the first stage of expansion, and Fig. 7C shows it in fully expanded state. The stmt 111 is supported on a guide wire 112, which is used to introduce and guide it to the desired location. In its folded position, stent 111 is covered with a covering envelope 113, which may be made of polymeric material, which keeps it in its folded state. Envelope 113 is connected to a retraction ring 114, which can be pulled away from stmt 111 by means not shown in the figure and well known to the skilled person. Looking now at Fig. 7B, when ring 114 is pulled away in the direction of the arrow, envelope 113 is pulled away with it, uncovering a portion of the stent, indicated at 115. Since the envelope no longer obliges this portion 115 to remain in the folded position, and since the normal position of the stent is expanded, this portion starts expanding to its natural, expanded state. This process is completed in Fig. 7C, when the envelope has been completely removed and the stent is in its fully expanded position. Because elastic forces operate to keep the stent expanded, its anchoring in its location is less susceptible of undesired displacement than balloon expanded stems. Of course, the guide wire is withdrawn from the patient after the positioning of the stent and its expansion is completed, as in any other similar procedure.
Looking now at Fig. 3A, a further preferred embodiment of the invention is illustrated, in which the same reference numerals are used to denote the artery parts. In this preferred embodiment of the invention, the deflecting device, generally indicated by numeral 70, is anchored within the internal carotid artery 40 with the deflecting member 72 extending downstream at the base of the substantially cylindrical deflecting member 70.
In accordance with this embodiment of the invention it is possible that the deflecting device 70 comprises a separate anchoring member 74 which is first deployed and anchored within the ICA 40 and then only the deflecting member 72 is attached thereto. According to a preferred embodiment of the invention, however, deflecting device 70 is inserted as schematically illustrated in Fig. 3B. In the first stage (Fig. 3B(1)), the device is folded so that the anchoring member 74 has a diameter of about 3 mm. The deflecting member 72 is protruding outside the tubular body of anchoring member 74. Fig. 3B(2) shows the second stage, in which partial expansion of anchoring body 74 has taken place, which leads to a partial retraction of deflecting member 72. Finally (Fig.
3B(3)), in the third stage the anchoring member 74 is fully expanded, to a diameter of about 7-9 mm, and deflecting member 72 has withdrawn to a plane substantially perpendicular to the axis of tubular anchoring member 74. According to this particular embodiment of the invention, deflecting member 72 has a net-like configuration.
Lines 78 schematically represent the flow of embolic material entering from the common carotid artery 38 and deflected into the ECA
42, rather than entering the ICA 40. Since the deflecting portion 72 is made of mesh material, on the other hand, blood is free to flow into the ICA 40. As will be appreciated by the skilled person, it is required that the mesh deflecting element be of a mesh size sufficient to allow passage of blood without hindrance, while occluding the passage of embolic material of predetermined size. Typically - but non-limitatively - the deflecting member is designed so as to prevent the passage of particles of a size in the range of 200 - 400 ~,m. This is a substantial improvement over the prior art that aims at excluding particles of about 1 cm diameter. This is made possible, according to the invention, by the fact that the device employed is a deflecting device, and thus clogging problems that are present in the prior art are of little concern when operating according to the invention.
In Fig. 4 there is illustrated another embodiment of a deflecting device, generally designated by numeral 80. This device differs from the embodiments of Figs. 1 and 2 in that its anchoring portion 82 mainly extends into the external carotid artery 42, with only a minor wall portion 84 thereof extending into the common carotid artery 38. It is noted that the deflecting member 86 is positioned across inlet 54 of the ICA 40.
Still another embodiment of a deflecting device 88 is illustrated in Fig. 5, which again is similar to the embodiments of Figs. 1, 2 and 4, the main difference being in the size and shape of the anchoring member 90. Different designs of deflecting members in accordance with the invention may be chosen by physicians for use in a given situation, depending on several physiological parameters of the patient. In the design of Fig. 5, the deflecting member 98 has its anchoring portion 90 extending within the common carotid artery 38, with a minor portion 94 bearing against a wall of the external carotid artery 42. Here again, it is noted that the deflecting member 98 extends across the inlet 54 of ICA
40.
It should be noted that the deflecting member in accordance with each of the embodiments of the invention is so sized and shaped as to facilitate correct positioning across the inlet of the internal carotid artery 40. For that purpose, it is required that the deflecting member be somewhat larger than the cross-sectional size of the inlet into the ICA.
Fig. 6 illustrates still a further embodiment of a deflecting device, according to another preferred embodiment of the invention, generally designated at 100, wherein the anchoring member 102 extends within the zone of bifurcation, with a wall portion 104 bearing against the common carotid artery 38 and a second portion 106 bearing against a _17_ wall portion of the external carotid artery 42. Deflecting surface 110 is similar to that of the previous embodiments, and extends across inlet 54 of the internal carotid artery 40.
The device of the invention can be constructed in a way very similar to cardiac stems, although the dimensions are different and, therefore, allow for greater constructive flexibility. However, the man of the art will easily recognize the materials and expandable shapes suitable to make the stmt of the invention. For instance, the stent and the deflecting device can be made of a material selected from nitinol, polymeric material, stainless steel, etc., and having a configuration selected fromzigzag shape and sinusoidal shape. The filtering means of the deflecting device, if used, should have the following dimensions, in order to effectively prevent the entrance of at least a major part of dangerous embolic material: >200-400 Vim. The diameter of the stent may somewhat vary for different individuals. However, the diameter in the closed state is Up to about 3 mm, while when expanded, the diameter may vary in the range of 5 mm to 10 mm. The diameter of the wire which makes up the body (or anchoring portion) of the device is preferably in the range 100 ~,m to 200 ~,m, while that of the wire used for the filtering device is preferably in the range of 1.0 ~,m to 200 ~,m. Of course, the entire device can also be constructed using the same dimensions, so that there is no difference in mesh size between the body of the device and its deflecting portion.
The device of the invention must fulfill certain predetermined conditions that will be detailed hereinafter. The skilled person will of course be able to devise various devices, of different shapes and properties, which fulfill said conditions. When testing a device of the invention under physiological conditions, namely:
Rea" = 200 - 500 BPM (beats per minute) = 40 - 180 Womersley = 2 - 7 wherein Rea" is the average Reynolds number, and Womersley is the dimensionless beat parameter;
the following conditions should preferably be met by the device of the invention:
1) RepmX between 0 and 4, preferably 1 or less (creeping or Stokes' slow) 2) 100 dyne/cm2> Shear Stress > 2 dyne/cm2 3) The generation of thrombin should not exceed 40 nmolelminute, as measured according to the thrombin acetylation test.
wherein Rep~X is the Reynolds number for the wire of which the deflecting element is made, and the shear stress is measured at the device. As will be appreciated by the skilled person, the smaller the RepmX number the better. However, devices attaining larger Rep~X
numbers than indicated above may also be provided, and the invention is by no means limited to any specific Rep~~ number.
The device of the invention can be utilized in a variety of ways. A
suitable procedure is illustrated in Fig. 8. In the figure, the ICA-ECA
bifurcation is shown, after treatment for a bifurcation lesion. The blood flows in the direction of the arrow. This lesion is treated as follows:
1. Firstly, the occlusions are opened using conventional angioplastic techniques;
2. Then, a normal stent 120 is introduced in the ICA;
3. The catheter used to introduce stent 120 is retracted, and the device of the invention, indicated by numeral 121, is then introduced. The resulting situation is seen in the figure.
Of course, the procedure and devices illustrated in Fig. 8 are only one option to treat a bifurcation lesion, and other alternative devices and methods exist, which are well known to the skilled person, and which are not described herein, for the sake of brevity.
The invention is useful in a variety of cases. Some illustrative indications are listed below:
I) Severe carotid stenosis with concomitant high risk proximal sources of emboli. These are, for instance:
- Protruding Aortic arch atheroma (more than 1/3 of symptomatic patients);
- Severe carotid stenosis with concomitant cardiac disease;
- Severe carotid stenosis in patients undergoing heart surgery (5% on the statistical basis of 600,000 coronary bypass surgery) 2) Embolic strokes from proximal sources (e.g., mechanical heart valves, Afib, LVT, protruding AAA). These are:
- Atrial fibrillation (2.5 million in the U.SA. in 1999);
- Mechanical heart valve (225,000 procedures performed annually in the U.S.A.);
- Patients at high risk for recurrent embolism for a certain period (S.B.E.);
- Patients at high risk for proximal emboli and absolute contraindications for anticoagulation;
- Patients at high risk for proximal emboli failing best medical treatment.
While some preferred embodiments of the invention have been illustrated and described in the specification, it will be understood by a skilled artisan that it is not intended thereby to limit the disclosure of the invention in any way, but rather it is intended to cover all modifications and arrangements falling within the scope and the spirit of the present invention. For example, the deflecting device may be a permanent device or may be removed from the vicinity of the carotid arteries at need. Furthermore, the deflecting member may be integrally formed with, or detachably connected to, the anchoring member, wherein in some instances it might be necessary first to position the anchoring member and then to attach the deflecting member.
Additionally, the deflecting member may be of different size, shape and pattern, depending on flow parameters and patient specific requirements.
It should also be noted that the flow ratio between the ICA and the ECA is about 4:1. This ratio also reflects the much higher risk of embolic material flowing into the ICA.
It is thus an object of the present invention to provide an implantable deflecting device suitable to be positioned within a blood vessel supplying blood to the brain, and further suitable to deflect embolic material that would have flown into the internal carotid artery, into the external carotid artery, thereby preventing the entry of said embolic material into the internal carotid artery, and thus preventing extracarnial embolus to occlude small intercarnial arteries in the brain.
It is another object of the invention to provide a method for treating a patient known to suffer from embolic diseases, by selectively occluding the passage of embolic material into the internal carotid artery.
It is yet another object of the invention to provide a method for preventing conditions associated with embolic material.
Other objects of the invention will become apparent as the description proceeds.
SUMMARY OF THE INVENTION
The present invention provides an implantable device for positioning in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), comprising a deflecting element suitable to deflect the flow of embolic material flowing in the CCA toward the ICA, into the ECA. Preferably, but non-limitatively, the deflecting element comprises filtering means.
Thus, in one aspect, the invention provides an implantable deflecting device comprising an anchoring member engageable with inner walls of a carotid artery, and one or more deflecting members for deflecting flow of embolic material into the ECA, substantially without obstructing blood flow into the ICA.
The anchoring member and the deflecting member may be integral with one another or attached or coupled to one another. In the present specification the anchoring member and the deflecting member may be referred to also as anchoring portion and deflecting portion, respectively.
In accordance with a particular preferred embodiment of the invention, the deflecting member is a screening element fitted at the inlet into the ICA and is adapted to prevent the passage into the ICA of embolic material above a predetermined size.
By a preferred embodiment, at least the anchoring member is a stmt adapted for insertion via the vasculature of an individual. The implantable deflecting device in accordance with any of the .6_ embodiments of the present invention may be permanently implanted or may be removed after a period of time, depending on the course of treatment and the medical procedure.
As will become evident from the description to follow, the deflecting member is preferably, but not compulsorily, positioned at the inlet into the internal carotid artery, whereas the anchoring member may be positioned in a variety of locations. The deflecting member, however, may be positioned at any location that fulfills two conditions:
firstly, it does not occlude the flow of blood into the ICA, and secondly, it causes a deflection of the flow of embolic material into the ECA. For instance, the deflecting member may be anchored in the ICA and protrude into the bifurcation zone, or may be positioned at the entrance to the ECA and extend toward the surrounding walls, for constructive and strength reasons.
In accordance with one specific embodiment of the invention, the anchoring member comprises a tubular portion for anchorage within the CCA with an upstream portion extending towards the bifurcation zone, said upstream portion accommodating the one or more deflecting member.
In accordance with still another preferred embodiment of the invention, the anchoring member comprises a tubular portion for anchoring within the ECA, with a downstream portion extending towards the bifurcation zone, said downstream portion accommodating the one or more deflecting member. Alternatively, the anchoring member comprises a tubular portion for anchorage within the ICA, with a downstream portion extending towards the bifurcation zone, said upstream portion accommodating the one or more deflecting member.
It will also be appreciated that the anchoring member may comprise a tubular portion for anchorage within a vascular portion extending along the CCA and .the ECA, wherein the one or more deflecting members is accommodated at the inlet to the ICA.
By one specific design the anchoring member comprises a tubular portion for anchorage at the bifurcation zone, wherein the one or more deflecting member is accommodated at or adjacent the inlet into the ICA.
The one or more deflecting member may be integrally formed with the anchoring member or may be attached or coupled thereto either during manufacture, or after implanting the anchoring member within the artery.
By another aspect of the present invention there is provided an implantable deflecting device for implanting at the vicinity of bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA); the device comprising an anchoring member engageable with inner walls of a carotid artery, and one or more deflecting members, wherein the one or more deflecting member is so positioned and sized so that embolic material encountering it is deflected to flow into the ECA.
_$_ In another aspect the invention is directed to an arterial stent suitable to be positioned in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), comprising a deflecting device.
The invention is further directed to an arterial stmt suitable to be positioned in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), coupled to a deflecting device.
Preferably, but non-limitatively, the aforementioned stents employ as a deflecting device an element comprising filtering means of dimensions suitable to allow the flow of blood to proceed into the ICA, while preventing the access thereto of embolic material of a predetermined size.
In a further aspect, the invention is directed to the prevention of the occurrence, or the recurrence, of cerebralvascular diseases, particularly of stroke, comprising 'preventing the flow of embolic material flowing in the CCA from accessing the ICA, by deflecting the flow of said embolic material into the ECA. Prevention of the cerebralvascular disease is achieved by implanting, permanently or temporarily, in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), a deflecting device according to the invention.
It should be emphasized that while throughout this specification reference is made to the bifurcation of the CCA into the ICA, this is done for the sake of brevity only, but the invention is in no way limited _g_ to this specific location. The invention can be advantageously be exploited at any other suitable bifurcation of blood vessels as existing, for instance, in the leg.
All the above and other characteristics and advantages of the invention will be better understood through the following illustrative and non-limitative detailed description of preferred embodiments thereof.
BRIEF DESCRIPTION OF THE DRAWINGS
In order to better understand the invention and to illustrate it in practice, non-limiting examples of some preferred embodiments will now be described, with reference to the accompanying drawings, in which:
Fig. 1A is a perspective view of a deflecting member in accordance with a preferred embodiment of the present invention;
Fig. 1B is a perspective view of a deflecting member according to another preferred embodiment of the invention, which is a modification of the device of Fig. 1A;
Fig. 2 illustrates the insertion and positioning of a device according to a preferred embodiment of the invention:
Fig. 2A schematically shows the deflecting device of Fig. 1, in .
collapsed form (i.e., prior to expansion into the artery), on its way to reach the arterial bifurcation; Fig. 2B schematically shows the deflecting device of Fig. 2A, during its expansion and positioning at the arterial bifurcation;
Fig. 2C shows a situation in which the device of Fig. 1 has been positioned in the bifurcation, and the deploying equipment has been withdrawn (normal working position);
Fig. 3A schematically illustrates a deflecting device in accordance with another embodiment of the invention, located within the internal carotid artery;
Fig. 3B schematically illustrates the stages of insertion of the device of Fig, 3A;
Fig. 4 is a deflecting device wherein the anchoring portion mainly extends into the external carotid artery;
Fig. 5 is a deflecting device in which the anchoring portion extends mainly in the common carotid artery;
Fig. 6 is a deflecting device in which the anchoring portion is located at the bifurcation zone;
Fig. 7 schematically illustrates the insertion of a self expandable device; and Fig. 8 schematically shows how to deal with a bifurcation lesion, according to one preferred embodiment of the invention.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
A deflecting device in accordance with a preferred embodiment of the present invention, generally designated 20, is shown in Fig. 1A. The deflecting device is made of fine wire woven into a net-like device having a construction suitable for expanding from a contracted position in which it is deployed through the vasculator of an individual, and expanded by means well known in the art, as will be further explained hereinafter with reference to Figs. 2A and 2B.
The deflecting device 20 has an essentially cylindrical shape with its body 22 generally serving as an anchoring portion. An anchoring portion is a portion of the device that firmly contacts the walls of the artery. Such contact causes a growth of the wall into the net of the devices, and strongly anchors it to the artery thus preventing its accidental displacement. The physiological processes leading to such anchoring are well known in the art, and will therefore not be discussed herein in detail, for the sake of brevity.
A deflecting portion 24 is constructed by a plurality of fine wires 26, parallelly extending along the longitudinal axis of the device and supported by two support wires 28. The deflecting portion 24 is integral with or attached to the anchoring portion 22.
The size and shape of the deflecting member is adjusted to match the inlet of the internal carotid artery as will be further explained hereinafter.
The embodiment of Fig. 1B is similar to that of Fig. lA. However, the deflecting device 21, which is essentially cylindrical, comprises a deflecting portion 25 which is not limited to a part of the circumference of the device, as is the deflecting portion 24 of Fig. 1A, but rather covers the whole circumference of the device. This arrangement, of course, is easier to use, inasmuch as there is no need to exactly match the limited area of the deflecting portion with the opening of the ICA. Furthermore, two markers 27 (which in the particular embodiment of Fig. 1B are circular in shape) are provided, which are radio opaque and serve to aid a physician in the proper positioning of the device within the artery. The markers are visible under radiographic equipment, and therefore can be used to follow the advancement of the device that bears them. Other markers can also be provided, as will be apparent to the skilled person.
For instance, markers 27a are gold points which may be used to position the device also with respect of its rotation around its axis.
The structure of the anchoring portion 29 and of the deflecting portion 25 is essentially similar to the structure illustrated with reference to Fig. lA. The difference resides mainly in the design of the deflecting portion, and in the provision of the markers.
Figs. 2A through 2Cillustrates a carotid artery portion, generally designated 36, in which the common carotid artery (CCA) is designated 38, the internal carotid artery (ICA) is designated 40, and the external carotid artery (ECA) is designated 42. For placing the deflecting device 20 seen in Fig. 1, conventional stmt deployment equipment may be used, which equipment typically comprises an expandable balloon 46, fitted at an end of an inflating tube 48 carried by a guide wire (not seen). However, the device may also be self expandable, as known per se, and as readily understood by the skilled person.
The arrangement is such that by using suitable imaging equipment, the assembly seen in Fig. 2A is inserted through the vasculator of an individual, into the CCA, until the deflecting device 20 is positioned within the bifurcation zone 52, with the deflecting member 24 extending opposite inlet 54 of ICA 40. In this position, balloon 46 is inflated, as shown in Fig. 2B, whereby the anchoring walls 22 of deflecting device 20 anchor against respective inner walls of the common carotid artery 38 and the external carotid artery 42, respectively, with the deflecting member 24 extending across inlet 54 of the internal carotid artery 40. Then, balloon 46 is deflated and is removed via the vasculator of the individual, and the deployment of the deflecting member 20 is thus completed, as seen in Fig. 2C. In this position, embolic material, which is schematically illustrated as particles flowing along flow lines 60 in Fig. 2C, flow in the common carotid artery 38, and upon meeting the deflecting member 24 they are prevented from entering the ICA 40, because their size is larger than the mesh of deflecting portion 24, and they are thus deflected into the external carotid artery 42.
The corresponding operation, when effected with a self expandable stmt, is illustrated in Fig. 7. As will be apparent to the skilled person, using a self expandable device is more convenient in many cases, because of the great mobility of the neck of the patient. The self expandable device, of course, provides for a better anchoring of the device.
Fig. 7A shows the stmt in folded state, Fig. 7B shows it during the first stage of expansion, and Fig. 7C shows it in fully expanded state. The stmt 111 is supported on a guide wire 112, which is used to introduce and guide it to the desired location. In its folded position, stent 111 is covered with a covering envelope 113, which may be made of polymeric material, which keeps it in its folded state. Envelope 113 is connected to a retraction ring 114, which can be pulled away from stmt 111 by means not shown in the figure and well known to the skilled person. Looking now at Fig. 7B, when ring 114 is pulled away in the direction of the arrow, envelope 113 is pulled away with it, uncovering a portion of the stent, indicated at 115. Since the envelope no longer obliges this portion 115 to remain in the folded position, and since the normal position of the stent is expanded, this portion starts expanding to its natural, expanded state. This process is completed in Fig. 7C, when the envelope has been completely removed and the stent is in its fully expanded position. Because elastic forces operate to keep the stent expanded, its anchoring in its location is less susceptible of undesired displacement than balloon expanded stems. Of course, the guide wire is withdrawn from the patient after the positioning of the stent and its expansion is completed, as in any other similar procedure.
Looking now at Fig. 3A, a further preferred embodiment of the invention is illustrated, in which the same reference numerals are used to denote the artery parts. In this preferred embodiment of the invention, the deflecting device, generally indicated by numeral 70, is anchored within the internal carotid artery 40 with the deflecting member 72 extending downstream at the base of the substantially cylindrical deflecting member 70.
In accordance with this embodiment of the invention it is possible that the deflecting device 70 comprises a separate anchoring member 74 which is first deployed and anchored within the ICA 40 and then only the deflecting member 72 is attached thereto. According to a preferred embodiment of the invention, however, deflecting device 70 is inserted as schematically illustrated in Fig. 3B. In the first stage (Fig. 3B(1)), the device is folded so that the anchoring member 74 has a diameter of about 3 mm. The deflecting member 72 is protruding outside the tubular body of anchoring member 74. Fig. 3B(2) shows the second stage, in which partial expansion of anchoring body 74 has taken place, which leads to a partial retraction of deflecting member 72. Finally (Fig.
3B(3)), in the third stage the anchoring member 74 is fully expanded, to a diameter of about 7-9 mm, and deflecting member 72 has withdrawn to a plane substantially perpendicular to the axis of tubular anchoring member 74. According to this particular embodiment of the invention, deflecting member 72 has a net-like configuration.
Lines 78 schematically represent the flow of embolic material entering from the common carotid artery 38 and deflected into the ECA
42, rather than entering the ICA 40. Since the deflecting portion 72 is made of mesh material, on the other hand, blood is free to flow into the ICA 40. As will be appreciated by the skilled person, it is required that the mesh deflecting element be of a mesh size sufficient to allow passage of blood without hindrance, while occluding the passage of embolic material of predetermined size. Typically - but non-limitatively - the deflecting member is designed so as to prevent the passage of particles of a size in the range of 200 - 400 ~,m. This is a substantial improvement over the prior art that aims at excluding particles of about 1 cm diameter. This is made possible, according to the invention, by the fact that the device employed is a deflecting device, and thus clogging problems that are present in the prior art are of little concern when operating according to the invention.
In Fig. 4 there is illustrated another embodiment of a deflecting device, generally designated by numeral 80. This device differs from the embodiments of Figs. 1 and 2 in that its anchoring portion 82 mainly extends into the external carotid artery 42, with only a minor wall portion 84 thereof extending into the common carotid artery 38. It is noted that the deflecting member 86 is positioned across inlet 54 of the ICA 40.
Still another embodiment of a deflecting device 88 is illustrated in Fig. 5, which again is similar to the embodiments of Figs. 1, 2 and 4, the main difference being in the size and shape of the anchoring member 90. Different designs of deflecting members in accordance with the invention may be chosen by physicians for use in a given situation, depending on several physiological parameters of the patient. In the design of Fig. 5, the deflecting member 98 has its anchoring portion 90 extending within the common carotid artery 38, with a minor portion 94 bearing against a wall of the external carotid artery 42. Here again, it is noted that the deflecting member 98 extends across the inlet 54 of ICA
40.
It should be noted that the deflecting member in accordance with each of the embodiments of the invention is so sized and shaped as to facilitate correct positioning across the inlet of the internal carotid artery 40. For that purpose, it is required that the deflecting member be somewhat larger than the cross-sectional size of the inlet into the ICA.
Fig. 6 illustrates still a further embodiment of a deflecting device, according to another preferred embodiment of the invention, generally designated at 100, wherein the anchoring member 102 extends within the zone of bifurcation, with a wall portion 104 bearing against the common carotid artery 38 and a second portion 106 bearing against a _17_ wall portion of the external carotid artery 42. Deflecting surface 110 is similar to that of the previous embodiments, and extends across inlet 54 of the internal carotid artery 40.
The device of the invention can be constructed in a way very similar to cardiac stems, although the dimensions are different and, therefore, allow for greater constructive flexibility. However, the man of the art will easily recognize the materials and expandable shapes suitable to make the stmt of the invention. For instance, the stent and the deflecting device can be made of a material selected from nitinol, polymeric material, stainless steel, etc., and having a configuration selected fromzigzag shape and sinusoidal shape. The filtering means of the deflecting device, if used, should have the following dimensions, in order to effectively prevent the entrance of at least a major part of dangerous embolic material: >200-400 Vim. The diameter of the stent may somewhat vary for different individuals. However, the diameter in the closed state is Up to about 3 mm, while when expanded, the diameter may vary in the range of 5 mm to 10 mm. The diameter of the wire which makes up the body (or anchoring portion) of the device is preferably in the range 100 ~,m to 200 ~,m, while that of the wire used for the filtering device is preferably in the range of 1.0 ~,m to 200 ~,m. Of course, the entire device can also be constructed using the same dimensions, so that there is no difference in mesh size between the body of the device and its deflecting portion.
The device of the invention must fulfill certain predetermined conditions that will be detailed hereinafter. The skilled person will of course be able to devise various devices, of different shapes and properties, which fulfill said conditions. When testing a device of the invention under physiological conditions, namely:
Rea" = 200 - 500 BPM (beats per minute) = 40 - 180 Womersley = 2 - 7 wherein Rea" is the average Reynolds number, and Womersley is the dimensionless beat parameter;
the following conditions should preferably be met by the device of the invention:
1) RepmX between 0 and 4, preferably 1 or less (creeping or Stokes' slow) 2) 100 dyne/cm2> Shear Stress > 2 dyne/cm2 3) The generation of thrombin should not exceed 40 nmolelminute, as measured according to the thrombin acetylation test.
wherein Rep~X is the Reynolds number for the wire of which the deflecting element is made, and the shear stress is measured at the device. As will be appreciated by the skilled person, the smaller the RepmX number the better. However, devices attaining larger Rep~X
numbers than indicated above may also be provided, and the invention is by no means limited to any specific Rep~~ number.
The device of the invention can be utilized in a variety of ways. A
suitable procedure is illustrated in Fig. 8. In the figure, the ICA-ECA
bifurcation is shown, after treatment for a bifurcation lesion. The blood flows in the direction of the arrow. This lesion is treated as follows:
1. Firstly, the occlusions are opened using conventional angioplastic techniques;
2. Then, a normal stent 120 is introduced in the ICA;
3. The catheter used to introduce stent 120 is retracted, and the device of the invention, indicated by numeral 121, is then introduced. The resulting situation is seen in the figure.
Of course, the procedure and devices illustrated in Fig. 8 are only one option to treat a bifurcation lesion, and other alternative devices and methods exist, which are well known to the skilled person, and which are not described herein, for the sake of brevity.
The invention is useful in a variety of cases. Some illustrative indications are listed below:
I) Severe carotid stenosis with concomitant high risk proximal sources of emboli. These are, for instance:
- Protruding Aortic arch atheroma (more than 1/3 of symptomatic patients);
- Severe carotid stenosis with concomitant cardiac disease;
- Severe carotid stenosis in patients undergoing heart surgery (5% on the statistical basis of 600,000 coronary bypass surgery) 2) Embolic strokes from proximal sources (e.g., mechanical heart valves, Afib, LVT, protruding AAA). These are:
- Atrial fibrillation (2.5 million in the U.SA. in 1999);
- Mechanical heart valve (225,000 procedures performed annually in the U.S.A.);
- Patients at high risk for recurrent embolism for a certain period (S.B.E.);
- Patients at high risk for proximal emboli and absolute contraindications for anticoagulation;
- Patients at high risk for proximal emboli failing best medical treatment.
While some preferred embodiments of the invention have been illustrated and described in the specification, it will be understood by a skilled artisan that it is not intended thereby to limit the disclosure of the invention in any way, but rather it is intended to cover all modifications and arrangements falling within the scope and the spirit of the present invention. For example, the deflecting device may be a permanent device or may be removed from the vicinity of the carotid arteries at need. Furthermore, the deflecting member may be integrally formed with, or detachably connected to, the anchoring member, wherein in some instances it might be necessary first to position the anchoring member and then to attach the deflecting member.
Additionally, the deflecting member may be of different size, shape and pattern, depending on flow parameters and patient specific requirements.
Claims (18)
1. An implantable device for positioning in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), comprising a deflecting element suitable to deflect the flow of embolic material flowing in the CCA toward the ICA, into the ECA, said deflecting element comprising mesh material for deflecting flow of embolic material into the ECA, substantially without obstructing blood flow into the ICA, said device further comprising an anchoring member engageable with inner walls of a carotid artery.
2. An implantable deflecting device according to claim 1, wherein at least the anchoring member is a stent adapted for insertion via the vasculature of an individual.
3. An implantable deflecting device according to claim 1 or 2, wherein the deflecting member is positioned at the inlet into the ICA.
4. An implantable deflecting device according to any one of claims 1 to 3, wherein the anchoring member comprises a tubular portion comprising one or more deflecting member.
5. An implantable deflecting device according to any one of claims 1 to 4, wherein the one or more defecting member is integrally formed with the anchoring member.
6. An implantable deflecting device according to any one of claims 1 to 5, wherein the one or more deflecting member comprises an array of parallel wires extending at or adjacent the inlet into the ICA.
7. A device according to any one of claims 1 to 6, which comprises an arterial stent.
8. A method for preventing the flow of embolic material flowing in the CCA from accessing the ICA, comprising deflecting the flow of said embolic material into the ECA.
9. A method according to claim 8, comprising implanting in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), a deflecting device comprising a deflecting element suitable to deflect the flow of embolic material flowing in the CCA toward the ICA, into the ECA.
10. A method for treating a patient suffering from, or suspected of suffering from, the generation of embolic material, comprising deflecting the flow of said embolic material into the ECA.
11, A method for preventing cerebralvascular diseases or their recurrence, comprising implanting in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), a deflecting device comprising a deflecting element suitable to deflect the flow of embolic material flowing in the CCA toward the ICA, into the ECA.
12. A method according to claim 11, wherein the cerebralvascular disease is a stroke.
13. A method according to any one of claims 8 to 12, wherein the deflecting device is provided in, or coupled to, a stent.
14. An implantable device according to claim 1, wherein the mesh material is made of wires having a thickness comprised between 15 -200 µ.
15. An implantable device according claim 14, wherein the filtering means are such that the Reynolds number for the wire under physiological conditions is between 0 and 4, preferably 1 or less.
16. An implantable deflecting device for positioning in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), essentially as described and illustrated.
17. An implantable device for positioning in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), comprising a deflecting element suitable to deflect the flow of embolic material flowing in the CCA toward the ICA, into the ECA, said deflecting element comprising mesh material for deflecting flow of embolic material into the ECA, substantially without obstructing blood flow into the ICA, said device further comprising an anchoring member engageable with inner walls of a carotid artery wherein said mesh material is provided with openings having a shape suitable to prevent the passage of particles of diameter smaller than 400µm.
18. An implantable device for positioning in the vicinity of the bifurcation of the common carotid artery (CCA) into the internal carotid artery (ICA) and the external carotid artery (ECA), comprising a deflecting element suitable to deflect the flow of anabolic material flowing in the CCA toward the ICA, into the ECA, said deflecting element comprising mesh material having a pore size less than 400µm and for deflecting flow of embolic material into the ECA, substantially without obstructing blood flow into the ICA, said device further comprising an anchoring member engageable with inner walls of a carotid artery.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12893899A IL128938A0 (en) | 1999-03-11 | 1999-03-11 | Implantable stroke treating device |
IL128938 | 1999-03-11 | ||
PCT/IL2000/000147 WO2000053119A1 (en) | 1999-03-11 | 2000-03-09 | Implantable stroke preventing device |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2364131A1 true CA2364131A1 (en) | 2000-09-14 |
Family
ID=11072587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002364131A Abandoned CA2364131A1 (en) | 1999-03-11 | 2000-03-09 | Implantable stroke preventing device |
Country Status (8)
Country | Link |
---|---|
US (2) | US6348063B1 (en) |
EP (2) | EP1158928A1 (en) |
JP (1) | JP2002537942A (en) |
AU (2) | AU3187600A (en) |
CA (1) | CA2364131A1 (en) |
HK (1) | HK1041805A1 (en) |
IL (1) | IL128938A0 (en) |
WO (2) | WO2000053118A1 (en) |
Families Citing this family (281)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6006134A (en) * | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US6676696B1 (en) * | 1998-02-12 | 2004-01-13 | Thomas R. Marotta | Endovascular prosthesis |
US6755856B2 (en) | 1998-09-05 | 2004-06-29 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
US6146370A (en) * | 1999-04-07 | 2000-11-14 | Coaxia, Inc. | Devices and methods for preventing distal embolization from the internal carotid artery using flow reversal by partial occlusion of the external carotid artery |
US7018406B2 (en) * | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US20070043435A1 (en) * | 1999-11-17 | 2007-02-22 | Jacques Seguin | Non-cylindrical prosthetic valve system for transluminal delivery |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8016877B2 (en) * | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
IT1311589B1 (en) * | 1999-11-22 | 2002-03-13 | Alberto Cremonesi | DEVICE FOR VASCULAR IMPLANTATION IN THE PERCUTANEOUS TREATMENT OF CAROTID INJURY. |
EP1237487A4 (en) * | 1999-12-06 | 2010-11-03 | Simcha Milo | Ultrasonic medical device |
US20040010308A1 (en) * | 2000-01-18 | 2004-01-15 | Mindguard Ltd. | Implantable composite device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation |
US20040010307A1 (en) * | 2000-01-18 | 2004-01-15 | Mindguard Ltd. | Implantable integral device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US7749245B2 (en) | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
US6692513B2 (en) | 2000-06-30 | 2004-02-17 | Viacor, Inc. | Intravascular filter with debris entrapment mechanism |
US6769434B2 (en) * | 2000-06-30 | 2004-08-03 | Viacor, Inc. | Method and apparatus for performing a procedure on a cardiac valve |
ATE396648T1 (en) * | 2000-05-09 | 2008-06-15 | Paieon Inc | SYSTEM AND METHOD FOR THREE-DIMENTIONAL RECONSTRUCTION OF AN ARTERY |
US6645221B1 (en) * | 2000-05-30 | 2003-11-11 | Zuli, Holdings Ltd. | Active arterial embolization filter |
AU2000260531A1 (en) * | 2000-06-20 | 2002-01-02 | Chf Solutions, Inc. | Implantable flow diversion device |
IL137326A0 (en) * | 2000-07-17 | 2001-07-24 | Mind Guard Ltd | Implantable braided stroke preventing device and method of manufacturing |
IL154433A0 (en) | 2000-08-18 | 2003-09-17 | Atritech Inc | Expandable implant devices for filtering blood flow from atrial appendages |
US20020186818A1 (en) * | 2000-08-29 | 2002-12-12 | Osteonet, Inc. | System and method for building and manipulating a centralized measurement value database |
WO2002039924A2 (en) * | 2000-11-17 | 2002-05-23 | Evysio Medical Devices Ulc | Endovascular prosthesis |
EP1337200A2 (en) * | 2000-11-17 | 2003-08-27 | Evysio Medical Devices Ulc | Endovascular prosthesis |
IL140870A0 (en) | 2001-01-11 | 2002-02-10 | Mind Guard Ltd | Deployment system for implantable self-expandable intraluminal devices |
EP1234554A1 (en) * | 2001-02-21 | 2002-08-28 | EndoArt SA | Vascular graft with internal deflector |
US7544206B2 (en) * | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
US8771302B2 (en) * | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
FR2826863B1 (en) * | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
US20030100945A1 (en) * | 2001-11-23 | 2003-05-29 | Mindguard Ltd. | Implantable intraluminal device and method of using same in treating aneurysms |
IL144213A0 (en) * | 2001-07-09 | 2002-05-23 | Mind Guard Ltd | Implantable filter |
FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US7097659B2 (en) * | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
CA2759746C (en) * | 2001-12-05 | 2018-05-22 | Smt Research And Development Ltd. | Endovascular device for entrapment of particulate matter and method for use |
US7147661B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
US8721713B2 (en) * | 2002-04-23 | 2014-05-13 | Medtronic, Inc. | System for implanting a replacement valve |
AU2003262938A1 (en) | 2002-08-27 | 2004-03-19 | Amir Belson | Embolic protection device |
CO5500017A1 (en) * | 2002-09-23 | 2005-03-31 | 3F Therapeutics Inc | MITRAL PROTESTIC VALVE |
US6899729B1 (en) * | 2002-12-18 | 2005-05-31 | Advanced Cardiovascular Systems, Inc. | Stent for treating vulnerable plaque |
US7220271B2 (en) | 2003-01-30 | 2007-05-22 | Ev3 Inc. | Embolic filters having multiple layers and controlled pore size |
US7323001B2 (en) | 2003-01-30 | 2008-01-29 | Ev3 Inc. | Embolic filters with controlled pore size |
US20040153119A1 (en) | 2003-01-30 | 2004-08-05 | Kusleika Richard S. | Embolic filters with a distal loop or no loop |
US7393339B2 (en) * | 2003-02-21 | 2008-07-01 | C. R. Bard, Inc. | Multi-lumen catheter with separate distal tips |
US7951557B2 (en) * | 2003-04-27 | 2011-05-31 | Protalix Ltd. | Human lysosomal proteins from plant cell culture |
US20100196345A1 (en) * | 2003-04-27 | 2010-08-05 | Protalix | Production of high mannose proteins in plant culture |
WO2004103209A2 (en) * | 2003-05-19 | 2004-12-02 | Secant Medical Llc | Tissue distention device and related methods for therapeutic intervention |
US20040267281A1 (en) * | 2003-06-25 | 2004-12-30 | Eran Harari | Delivery system for self-expandable diverter |
US9579194B2 (en) * | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
US7056286B2 (en) | 2003-11-12 | 2006-06-06 | Adrian Ravenscroft | Medical device anchor and delivery system |
US7186265B2 (en) * | 2003-12-10 | 2007-03-06 | Medtronic, Inc. | Prosthetic cardiac valves and systems and methods for implanting thereof |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
US7824443B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Medical implant delivery and deployment tool |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US20050137686A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical, A Delaware Corporation | Externally expandable heart valve anchor and method |
US7445631B2 (en) * | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7329279B2 (en) * | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8287584B2 (en) * | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US20050137691A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical | Two piece heart valve and anchor |
US7780725B2 (en) * | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US7959666B2 (en) * | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
US7381219B2 (en) * | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
US9005273B2 (en) * | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US8052749B2 (en) * | 2003-12-23 | 2011-11-08 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US9526609B2 (en) * | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US20050137696A1 (en) * | 2003-12-23 | 2005-06-23 | Sadra Medical | Apparatus and methods for protecting against embolization during endovascular heart valve replacement |
EP2526895B1 (en) * | 2003-12-23 | 2014-01-29 | Sadra Medical, Inc. | Repositionable heart valve |
US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US7748389B2 (en) * | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US20050182436A1 (en) * | 2004-02-18 | 2005-08-18 | Scimed Life Systems, Inc. | Apparatus and method for creating working channel through tissue |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
JP5290573B2 (en) | 2004-04-23 | 2013-09-18 | メドトロニック スリーエフ セラピューティクス,インコーポレイティド | Implantable prosthetic valve |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
ES2607402T3 (en) | 2004-05-25 | 2017-03-31 | Covidien Lp | Flexible vascular occlusion device |
KR101300437B1 (en) | 2004-05-25 | 2013-08-26 | 코비디엔 엘피 | Vascular stenting for aneurysms |
US8617234B2 (en) * | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
US20060206200A1 (en) * | 2004-05-25 | 2006-09-14 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
US8628564B2 (en) * | 2004-05-25 | 2014-01-14 | Covidien Lp | Methods and apparatus for luminal stenting |
US20060052867A1 (en) | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
WO2006042114A1 (en) * | 2004-10-06 | 2006-04-20 | Cook, Inc. | Emboli capturing device having a coil and method for capturing emboli |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
KR20070094888A (en) * | 2004-11-19 | 2007-09-27 | 메드트로닉 인코포레이티드 | Method and apparatus for treatment of cardiac valves |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
ITTO20050074A1 (en) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | CARDIAC VALVE PROSTHESIS |
US7955351B2 (en) | 2005-02-18 | 2011-06-07 | Tyco Healthcare Group Lp | Rapid exchange catheters and embolic protection devices |
US8945169B2 (en) | 2005-03-15 | 2015-02-03 | Cook Medical Technologies Llc | Embolic protection device |
US8221446B2 (en) | 2005-03-15 | 2012-07-17 | Cook Medical Technologies | Embolic protection device |
US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US20060259132A1 (en) * | 2005-05-02 | 2006-11-16 | Cook Incorporated | Vascular stent for embolic protection |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
AU2005332044B2 (en) | 2005-05-25 | 2012-01-19 | Covidien Lp | System and method for delivering and deploying and occluding device within a vessel |
US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
EP1898836A2 (en) * | 2005-06-10 | 2008-03-19 | Sagax Inc. | Implant device particularly useful for implantation in the intravascular system for diverting emboli |
US8109962B2 (en) | 2005-06-20 | 2012-02-07 | Cook Medical Technologies Llc | Retrievable device having a reticulation portion with staggered struts |
US7850708B2 (en) * | 2005-06-20 | 2010-12-14 | Cook Incorporated | Embolic protection device having a reticulated body with staggered struts |
US7771452B2 (en) | 2005-07-12 | 2010-08-10 | Cook Incorporated | Embolic protection device with a filter bag that disengages from a basket |
US7766934B2 (en) * | 2005-07-12 | 2010-08-03 | Cook Incorporated | Embolic protection device with an integral basket and bag |
US20070021816A1 (en) * | 2005-07-21 | 2007-01-25 | The Research Foundation Of State University Of New York | Stent vascular intervention device and methods for treating aneurysms |
US8187298B2 (en) * | 2005-08-04 | 2012-05-29 | Cook Medical Technologies Llc | Embolic protection device having inflatable frame |
US7712606B2 (en) | 2005-09-13 | 2010-05-11 | Sadra Medical, Inc. | Two-part package for medical implant |
US8377092B2 (en) | 2005-09-16 | 2013-02-19 | Cook Medical Technologies Llc | Embolic protection device |
EP1945142B1 (en) | 2005-09-26 | 2013-12-25 | Medtronic, Inc. | Prosthetic cardiac and venous valves |
US8632562B2 (en) * | 2005-10-03 | 2014-01-21 | Cook Medical Technologies Llc | Embolic protection device |
US8182508B2 (en) * | 2005-10-04 | 2012-05-22 | Cook Medical Technologies Llc | Embolic protection device |
US8252017B2 (en) * | 2005-10-18 | 2012-08-28 | Cook Medical Technologies Llc | Invertible filter for embolic protection |
US8216269B2 (en) | 2005-11-02 | 2012-07-10 | Cook Medical Technologies Llc | Embolic protection device having reduced profile |
US20070100372A1 (en) * | 2005-11-02 | 2007-05-03 | Cook Incorporated | Embolic protection device having a filter |
US20070112372A1 (en) * | 2005-11-17 | 2007-05-17 | Stephen Sosnowski | Biodegradable vascular filter |
US8152831B2 (en) * | 2005-11-17 | 2012-04-10 | Cook Medical Technologies Llc | Foam embolic protection device |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US9078781B2 (en) * | 2006-01-11 | 2015-07-14 | Medtronic, Inc. | Sterile cover for compressible stents used in percutaneous device delivery systems |
EP1988851A2 (en) | 2006-02-14 | 2008-11-12 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US8152833B2 (en) | 2006-02-22 | 2012-04-10 | Tyco Healthcare Group Lp | Embolic protection systems having radiopaque filter mesh |
EP2004095B1 (en) | 2006-03-28 | 2019-06-12 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US7625403B2 (en) | 2006-04-04 | 2009-12-01 | Medtronic Vascular, Inc. | Valved conduit designed for subsequent catheter delivered valve therapy |
US7740655B2 (en) * | 2006-04-06 | 2010-06-22 | Medtronic Vascular, Inc. | Reinforced surgical conduit for implantation of a stented valve therein |
US7524331B2 (en) * | 2006-04-06 | 2009-04-28 | Medtronic Vascular, Inc. | Catheter delivered valve having a barrier to provide an enhanced seal |
US7591848B2 (en) | 2006-04-06 | 2009-09-22 | Medtronic Vascular, Inc. | Riveted stent valve for percutaneous use |
US20070239269A1 (en) * | 2006-04-07 | 2007-10-11 | Medtronic Vascular, Inc. | Stented Valve Having Dull Struts |
US20070239271A1 (en) * | 2006-04-10 | 2007-10-11 | Than Nguyen | Systems and methods for loading a prosthesis onto a minimally invasive delivery system |
US20070244545A1 (en) * | 2006-04-14 | 2007-10-18 | Medtronic Vascular, Inc. | Prosthetic Conduit With Radiopaque Symmetry Indicators |
US20070244544A1 (en) * | 2006-04-14 | 2007-10-18 | Medtronic Vascular, Inc. | Seal for Enhanced Stented Valve Fixation |
US20070244546A1 (en) * | 2006-04-18 | 2007-10-18 | Medtronic Vascular, Inc. | Stent Foundation for Placement of a Stented Valve |
US8062324B2 (en) * | 2006-05-08 | 2011-11-22 | S.M.T. Research And Development Ltd. | Device and method for vascular filter |
WO2008031033A2 (en) * | 2006-09-07 | 2008-03-13 | Spence Paul A | Ultrasonic implant, systems and methods related to diverting material in blood flow away from the head |
US20100179647A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Methods of reducing embolism to cerebral circulation as a consequence of an index cardiac procedure |
US9480548B2 (en) * | 2006-09-11 | 2016-11-01 | Edwards Lifesciences Ag | Embolic protection device and method of use |
US9339367B2 (en) * | 2006-09-11 | 2016-05-17 | Edwards Lifesciences Ag | Embolic deflection device |
US20100179583A1 (en) * | 2006-09-11 | 2010-07-15 | Carpenter Judith T | Methods of deploying and retrieving an embolic diversion device |
US8460335B2 (en) * | 2006-09-11 | 2013-06-11 | Embrella Cardiovascular, Inc. | Method of deflecting emboli from the cerebral circulation |
US11304800B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US8876895B2 (en) | 2006-09-19 | 2014-11-04 | Medtronic Ventor Technologies Ltd. | Valve fixation member having engagement arms |
US8834564B2 (en) * | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
US20080071307A1 (en) * | 2006-09-19 | 2008-03-20 | Cook Incorporated | Apparatus and methods for in situ embolic protection |
WO2008047354A2 (en) | 2006-10-16 | 2008-04-24 | Ventor Technologies Ltd. | Transapical delivery system with ventriculo-arterial overflow bypass |
US20080161825A1 (en) * | 2006-11-20 | 2008-07-03 | Stout Medical Group, L.P. | Anatomical measurement tool |
US9107734B2 (en) | 2006-11-29 | 2015-08-18 | Emboline, Inc. | Embolic protection device |
WO2008070797A2 (en) | 2006-12-06 | 2008-06-12 | Medtronic Corevalve, Inc. | System and method for transapical delivery of an annulus anchored self-expanding valve |
JP2010512231A (en) * | 2006-12-12 | 2010-04-22 | スペンス、ポール・エー | Implant, system and method for physically diverting substances in blood to avoid head |
US20080262593A1 (en) * | 2007-02-15 | 2008-10-23 | Ryan Timothy R | Multi-layered stents and methods of implanting |
WO2008103295A2 (en) * | 2007-02-16 | 2008-08-28 | Medtronic, Inc. | Replacement prosthetic heart valves and methods of implantation |
US9901434B2 (en) | 2007-02-27 | 2018-02-27 | Cook Medical Technologies Llc | Embolic protection device including a Z-stent waist band |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
FR2915087B1 (en) | 2007-04-20 | 2021-11-26 | Corevalve Inc | IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT. |
EP3366762B1 (en) * | 2007-05-07 | 2020-07-08 | Protalix Ltd. | Large scale disposable bioreactor |
US8128679B2 (en) | 2007-05-23 | 2012-03-06 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with torque-absorbing connectors |
US8747458B2 (en) * | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
US9138307B2 (en) | 2007-09-14 | 2015-09-22 | Cook Medical Technologies Llc | Expandable device for treatment of a stricture in a body vessel |
US8419748B2 (en) * | 2007-09-14 | 2013-04-16 | Cook Medical Technologies Llc | Helical thrombus removal device |
US8252018B2 (en) * | 2007-09-14 | 2012-08-28 | Cook Medical Technologies Llc | Helical embolic protection device |
US9034007B2 (en) * | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US20090138079A1 (en) * | 2007-10-10 | 2009-05-28 | Vector Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US8920488B2 (en) | 2007-12-20 | 2014-12-30 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having a stable architecture |
EP3572045B1 (en) | 2008-01-24 | 2022-12-21 | Medtronic, Inc. | Stents for prosthetic heart valves |
US20090287290A1 (en) * | 2008-01-24 | 2009-11-19 | Medtronic, Inc. | Delivery Systems and Methods of Implantation for Prosthetic Heart Valves |
US8157853B2 (en) * | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US9149358B2 (en) * | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
WO2009094501A1 (en) * | 2008-01-24 | 2009-07-30 | Medtronic, Inc. | Markers for prosthetic heart valves |
EP2254513B1 (en) * | 2008-01-24 | 2015-10-28 | Medtronic, Inc. | Stents for prosthetic heart valves |
US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
ES2903231T3 (en) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
US20090264989A1 (en) * | 2008-02-28 | 2009-10-22 | Philipp Bonhoeffer | Prosthetic heart valve systems |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
AU2009232400B2 (en) | 2008-04-03 | 2013-09-12 | Cook Medical Technologies Llc | Self cleaning devices, systems and methods of use |
US8430927B2 (en) * | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
US8312825B2 (en) * | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
US8696743B2 (en) * | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
EP2119417B2 (en) | 2008-05-16 | 2020-04-29 | Sorin Group Italia S.r.l. | Atraumatic prosthetic heart valve prosthesis |
BRPI0918573A2 (en) | 2008-09-04 | 2015-12-01 | Anders Jönsson | temporary embolic protection device and medical procedure for its distribution |
US8998981B2 (en) * | 2008-09-15 | 2015-04-07 | Medtronic, Inc. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
US8852225B2 (en) * | 2008-09-25 | 2014-10-07 | Medtronic, Inc. | Emboli guarding device |
CA2739961A1 (en) | 2008-10-10 | 2010-04-15 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US8137398B2 (en) * | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
ES2551694T3 (en) | 2008-12-23 | 2015-11-23 | Sorin Group Italia S.R.L. | Expandable prosthetic valve with anchoring appendages |
US8388644B2 (en) | 2008-12-29 | 2013-03-05 | Cook Medical Technologies Llc | Embolic protection device and method of use |
US8641753B2 (en) * | 2009-01-31 | 2014-02-04 | Cook Medical Technologies Llc | Preform for and an endoluminal prosthesis |
US8361095B2 (en) * | 2009-02-17 | 2013-01-29 | Cook Medical Technologies Llc | Loop thrombectomy device |
US20100211094A1 (en) * | 2009-02-18 | 2010-08-19 | Cook Incorporated | Umbrella distal embolic protection device |
US20100274277A1 (en) * | 2009-04-27 | 2010-10-28 | Cook Incorporated | Embolic protection device with maximized flow-through |
EP2246011B1 (en) | 2009-04-27 | 2014-09-03 | Sorin Group Italia S.r.l. | Prosthetic vascular conduit |
US20100318180A1 (en) * | 2009-06-15 | 2010-12-16 | Boston Scientific Scimed, Inc. | Multi-layer stent assembly |
US8808369B2 (en) * | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
EP2496189A4 (en) | 2009-11-04 | 2016-05-11 | Nitinol Devices And Components Inc | Alternating circumferential bridge stent design and methods for use thereof |
WO2011081814A1 (en) | 2009-12-28 | 2011-07-07 | Cook Medical Technologies Llc | Endoluminal device with kink-resistant regions |
US9226826B2 (en) * | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
IT1400327B1 (en) | 2010-05-21 | 2013-05-24 | Sorin Biomedica Cardio Srl | SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT. |
BR112012029896A2 (en) | 2010-05-25 | 2017-06-20 | Jenavalve Tech Inc | prosthetic heart valve for stent graft and stent graft |
US9918833B2 (en) | 2010-09-01 | 2018-03-20 | Medtronic Vascular Galway | Prosthetic valve support structure |
EP4119107A3 (en) | 2010-09-10 | 2023-02-15 | Boston Scientific Limited | Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device |
EP2624791B1 (en) | 2010-10-08 | 2017-06-21 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design |
EP2486893B1 (en) | 2011-02-14 | 2017-07-05 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
EP2486894B1 (en) | 2011-02-14 | 2021-06-09 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
WO2012127309A1 (en) | 2011-03-21 | 2012-09-27 | Ontorfano Matteo | Disk-based valve apparatus and method for the treatment of valve dysfunction |
EP2520251A1 (en) | 2011-05-05 | 2012-11-07 | Symetis SA | Method and Apparatus for Compressing Stent-Valves |
AU2012203620B9 (en) | 2011-06-24 | 2014-10-02 | Cook Medical Technologies Llc | Helical Stent |
WO2013009975A1 (en) | 2011-07-12 | 2013-01-17 | Boston Scientific Scimed, Inc. | Coupling system for medical devices |
US9131926B2 (en) | 2011-11-10 | 2015-09-15 | Boston Scientific Scimed, Inc. | Direct connect flush system |
US8940014B2 (en) | 2011-11-15 | 2015-01-27 | Boston Scientific Scimed, Inc. | Bond between components of a medical device |
US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US9510945B2 (en) | 2011-12-20 | 2016-12-06 | Boston Scientific Scimed Inc. | Medical device handle |
US9277993B2 (en) | 2011-12-20 | 2016-03-08 | Boston Scientific Scimed, Inc. | Medical device delivery systems |
EP2842517A1 (en) | 2011-12-29 | 2015-03-04 | Sorin Group Italia S.r.l. | A kit for implanting prosthetic vascular conduits |
EP2800602B1 (en) | 2012-01-06 | 2017-08-02 | Emboline, Inc. | Integrated embolic protection devices |
US10172708B2 (en) | 2012-01-25 | 2019-01-08 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
US9861464B2 (en) * | 2012-04-13 | 2018-01-09 | Regents Of The University Of Minnesota | Cardio-embolic stroke prevention |
US9883941B2 (en) | 2012-06-19 | 2018-02-06 | Boston Scientific Scimed, Inc. | Replacement heart valve |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
US9414752B2 (en) | 2012-11-09 | 2016-08-16 | Elwha Llc | Embolism deflector |
US10219924B2 (en) | 2012-12-26 | 2019-03-05 | Stryker Corporation | Multilayer stent |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9968433B2 (en) | 2013-03-01 | 2018-05-15 | St. Jude Medical, Cardiology Division, Inc. | Embolic protection pass through tube |
US10973618B2 (en) * | 2013-03-01 | 2021-04-13 | St. Jude Medical, Cardiology Division, Inc. | Embolic protection device |
US9888993B2 (en) | 2013-03-01 | 2018-02-13 | St. Jude Medical, Cardiology Division, Inc. | Embolic protection device |
US8690907B1 (en) | 2013-03-15 | 2014-04-08 | Insera Therapeutics, Inc. | Vascular treatment methods |
CN105228688B (en) | 2013-03-15 | 2019-02-19 | 伊瑟拉医疗公司 | Vascular treatment device and method |
US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
US9629718B2 (en) | 2013-05-03 | 2017-04-25 | Medtronic, Inc. | Valve delivery tool |
US8870948B1 (en) | 2013-07-17 | 2014-10-28 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
WO2015028209A1 (en) | 2013-08-30 | 2015-03-05 | Jenavalve Technology Gmbh | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
WO2015173646A1 (en) * | 2014-05-16 | 2015-11-19 | Veosource Sa | Implantable self-cleaning blood filters |
US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
US9492273B2 (en) | 2014-12-09 | 2016-11-15 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
US10449043B2 (en) | 2015-01-16 | 2019-10-22 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
US10201417B2 (en) | 2015-02-03 | 2019-02-12 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
RU2597408C1 (en) * | 2015-05-08 | 2016-09-10 | Валерий Вильгельмович Петрашкевич | Intravascular expansion implant |
AU2016262564B2 (en) | 2015-05-14 | 2020-11-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
WO2018136959A1 (en) | 2017-01-23 | 2018-07-26 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
EP3294220B1 (en) | 2015-05-14 | 2023-12-06 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
US10335277B2 (en) | 2015-07-02 | 2019-07-02 | Boston Scientific Scimed Inc. | Adjustable nosecone |
US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
US10779940B2 (en) | 2015-09-03 | 2020-09-22 | Boston Scientific Scimed, Inc. | Medical device handle |
US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
EP3416568A4 (en) | 2016-02-16 | 2019-10-16 | Insera Therapeutics, Inc. | Aspiration devices and anchored flow diverting devices |
US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
CN109475419B (en) | 2016-05-13 | 2021-11-09 | 耶拿阀门科技股份有限公司 | Heart valve prosthesis delivery systems and methods for delivering heart valve prostheses through guide sheaths and loading systems |
US10245136B2 (en) | 2016-05-13 | 2019-04-02 | Boston Scientific Scimed Inc. | Containment vessel with implant sheathing guide |
US10201416B2 (en) | 2016-05-16 | 2019-02-12 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
WO2017218877A1 (en) | 2016-06-17 | 2017-12-21 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
EP4209196A1 (en) | 2017-01-23 | 2023-07-12 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
EP3634311A1 (en) | 2017-06-08 | 2020-04-15 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
EP3661458A1 (en) | 2017-08-01 | 2020-06-10 | Boston Scientific Scimed, Inc. | Medical implant locking mechanism |
CN111225633B (en) | 2017-08-16 | 2022-05-31 | 波士顿科学国际有限公司 | Replacement heart valve coaptation assembly |
JP7047106B2 (en) | 2018-01-19 | 2022-04-04 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Medical device delivery system with feedback loop |
WO2019144069A2 (en) | 2018-01-19 | 2019-07-25 | Boston Scientific Scimed, Inc. | Inductance mode deployment sensors for transcatheter valve system |
EP3749252A1 (en) | 2018-02-07 | 2020-12-16 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
WO2019165394A1 (en) | 2018-02-26 | 2019-08-29 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
EP3793478A1 (en) | 2018-05-15 | 2021-03-24 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
CN112437649A (en) | 2018-05-23 | 2021-03-02 | 索林集团意大利有限责任公司 | Heart valve prosthesis |
US11241310B2 (en) | 2018-06-13 | 2022-02-08 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
US11241312B2 (en) | 2018-12-10 | 2022-02-08 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
WO2020168091A1 (en) | 2019-02-13 | 2020-08-20 | Emboline, Inc. | Catheter with integrated embolic protection device |
US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
CN114650788A (en) * | 2019-09-11 | 2022-06-21 | 英华腾科技有限公司 | Apparatus and method for controlling flow of embolic material |
WO2023239784A1 (en) * | 2022-06-07 | 2023-12-14 | Edwards Lifesciences Corporation | Cardiovascular implant devices with flow conditioners to minimize disruption to and enhance cardiovascular hemodynamics |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2517194B1 (en) * | 1981-12-02 | 1985-08-09 | Esswein Sa | DISHWASHER USING A LIMITED QUANTITY OF WATER |
SE450809B (en) * | 1985-04-10 | 1987-08-03 | Medinvent Sa | PLANT TOPIC PROVIDED FOR MANUFACTURING A SPIRAL SPRING SUITABLE FOR TRANSLUMINAL IMPLANTATION AND MANUFACTURED SPIRAL SPRINGS |
US5876367A (en) * | 1996-12-05 | 1999-03-02 | Embol-X, Inc. | Cerebral protection during carotid endarterectomy and downstream vascular protection during other surgeries |
US5807330A (en) * | 1996-12-16 | 1998-09-15 | University Of Southern California | Angioplasty catheter |
JP4083241B2 (en) * | 1997-04-23 | 2008-04-30 | アーテミス・メディカル・インコーポレイテッド | Bifurcated stent and distal protection system |
US6087322A (en) | 1997-04-24 | 2000-07-11 | The Procter & Gamble Company | Fragrance pro-accords |
US6258120B1 (en) * | 1997-12-23 | 2001-07-10 | Embol-X, Inc. | Implantable cerebral protection device and methods of use |
CA2235911C (en) | 1997-05-27 | 2003-07-29 | Schneider (Usa) Inc. | Stent and stent-graft for treating branched vessels |
CH691846A5 (en) | 1997-06-20 | 2001-11-15 | Ecole Polytech | intravascular implant expansion deflector. |
US5951599A (en) * | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
US5941896A (en) * | 1997-09-08 | 1999-08-24 | Montefiore Hospital And Medical Center | Filter and method for trapping emboli during endovascular procedures |
US6146370A (en) * | 1999-04-07 | 2000-11-14 | Coaxia, Inc. | Devices and methods for preventing distal embolization from the internal carotid artery using flow reversal by partial occlusion of the external carotid artery |
US6312463B1 (en) * | 2000-02-01 | 2001-11-06 | Endotex Interventional Systems, Inc. | Micro-porous mesh stent with hybrid structure |
-
1999
- 1999-03-11 IL IL12893899A patent/IL128938A0/en unknown
-
2000
- 2000-01-18 US US09/484,965 patent/US6348063B1/en not_active Expired - Fee Related
- 2000-03-09 EP EP00909597A patent/EP1158928A1/en not_active Withdrawn
- 2000-03-09 JP JP2000603610A patent/JP2002537942A/en active Pending
- 2000-03-09 EP EP00909599A patent/EP1162926A1/en not_active Withdrawn
- 2000-03-09 WO PCT/IL2000/000145 patent/WO2000053118A1/en not_active Application Discontinuation
- 2000-03-09 WO PCT/IL2000/000147 patent/WO2000053119A1/en active IP Right Grant
- 2000-03-09 AU AU31876/00A patent/AU3187600A/en not_active Abandoned
- 2000-03-09 CA CA002364131A patent/CA2364131A1/en not_active Abandoned
- 2000-03-09 AU AU31878/00A patent/AU766582B2/en not_active Ceased
-
2001
- 2001-09-10 US US09/950,027 patent/US6866680B2/en not_active Expired - Fee Related
-
2002
- 2002-05-17 HK HK02103740.5A patent/HK1041805A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002537942A (en) | 2002-11-12 |
US6866680B2 (en) | 2005-03-15 |
AU766582B2 (en) | 2003-10-16 |
US20020049491A1 (en) | 2002-04-25 |
HK1041805A1 (en) | 2002-07-26 |
WO2000053119A8 (en) | 2001-06-07 |
EP1162926A1 (en) | 2001-12-19 |
AU3187800A (en) | 2000-09-28 |
US6348063B1 (en) | 2002-02-19 |
IL128938A0 (en) | 2000-02-17 |
WO2000053119A1 (en) | 2000-09-14 |
AU3187600A (en) | 2000-09-28 |
WO2000053118A1 (en) | 2000-09-14 |
EP1158928A1 (en) | 2001-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6348063B1 (en) | Implantable stroke treating device | |
US6673089B1 (en) | Implantable stroke treating device | |
US20040167613A1 (en) | Implantable stroke prevention device | |
US11819431B2 (en) | Apparatus and method for deploying an implantable device within the body | |
US11510795B2 (en) | Apparatus and method for deploying an implantable device within the body | |
US20040010308A1 (en) | Implantable composite device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation | |
JP4801655B2 (en) | Stent capable of intravascular supply for strengthening abnormal parts of blood vessels | |
ES2573843T3 (en) | Braided stent intended to be implanted in a blood vessel | |
JP4901872B2 (en) | Method and apparatus for treating thoracic aortic aneurysm | |
CA2033195C (en) | Aortic graft and method for repairing aneurysm | |
US20040010307A1 (en) | Implantable integral device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation | |
US20070055365A1 (en) | Stent with integrated filter | |
US20040024416A1 (en) | Implantable braided stroke preventing device and method of manufacturing | |
EP2522313A1 (en) | Vascular implants and methods of fabricating the same | |
US20080065191A1 (en) | Prosthesis systems and methods | |
JP2003245359A (en) | Coated segment type stent | |
JP2010512231A (en) | Implant, system and method for physically diverting substances in blood to avoid head | |
US20230149192A1 (en) | Expandable stent and a method for promoting a natural intracranial angiogenesis process, and use of the expandable stent in the method for promoting a natural intracranial angiogenesis process | |
EP1399214A2 (en) | Implantable composite device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation | |
US7815656B2 (en) | Method for endovascular bypass stent graft delivery | |
WO2002055123A2 (en) | Implantable integral device and corresponding method for deflecting embolic material in blood flowing at an arterial bifurcation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |